13589-02-1 (H-PRO-PHE-OH,H-PRO-PHE-OH)

快速询单

结构式：

H-PRO-PHE-OHMOL文件

CAS号：

13589-02-1

中文名称：

H-PRO-PHE-OH

英文名称：

H-PRO-PHE-OH

分子式：

C₁₄H₁₈N₂O₃

分子量：

262.304323673248

简介：

H-Pro-Phe-OH 是一种含脯氨酸和苯丙氨酸的二肽，可作为脯氨酸酶的底物。H-Pro-Phe-OH 也能用于多肽的合成，其中苯丙氨酸是一种芳香族氨基酸，能抑制血管紧张素转换酶 (ACE，HY-P2983) 的活性。

H-PRO-PHE-OH(13589-02-1)名称与标识符

名称

英文别名：

L-Phenylalanine,L-prolyl-;H-Pro-Phe-OH;PRO-PHE CRYSTALLINE;H-L-Pro-L-Phe-OH;L-Pro-L-Phe;L-Pro-L-Phe-OH;L-prolyl-L-phenylalanine;N-L-Prolyl-L-phenylalanine;PROLINE-PHENYLALANINE;PRO-PHE;Pro-Phe-OH;pro-phecrystalline;

标识符

MDL：

MFCD00037869

InChIKey：

IWIANZLCJVYEFX-RYUDHWBXSA-N

Inchi：

1S/C14H18N2O3/c17-13(11-7-4-8-15-11)16-12(14(18)19)9-10-5-2-1-3-6-10/h1-3,5-6,11-12,15H,4,7-9H2,(H,16,17)(H,18,19)/t11-,12-/m0/s1

SMILES：

O=C([C@@H]1CCCN1)N[C@H](C(=O)O)CC1C=CC=CC=1

H-PRO-PHE-OH(13589-02-1)物化性质

实验特性

LogP : 1.27020
PSA : 78.43000

计算特性

精确分子量 : 262.13200

H-PRO-PHE-OH(13589-02-1)推荐厂家更多厂家(8)

公司名称	手机号/电话	联系人	QQ	询单
杭州贝普泰生物医药有限公司	15888826472 0571-85350119	刘经理	1971401266	询单
杭州肽佳生物科技有限公司	13336049365 0571-87213919	来经理	3007955256	询单
上海源叶生物科技有限公司	15026964105 15026964105	汤思磊	2881489226	询单
上海瀚思化工有限公司	18939883912 021-34536277	顾经理	3003949364	询单
江苏艾康生物医药研发有限公司	18795912720 025-66061636	杨情情	3004779232	询单
四川维克奇生物科技有限公司	13348961525	杨洋	2851167780	询单
吉尔生化（上海）有限公司	13585649920 021-61263375	陈琳	2335292964	询单
南京莱昂生物科技有限公司	13813004896 025-86897023	李通敏	295304020	询单

H-PRO-PHE-OH(13589-02-1)相关文献

1. An l-proline-modified chiral porous hyper-crosslinked l-phenylalanine dipeptide—increased reaction rate and selectivity in asymmetric catalysis
Yaodong Wang,Lijia Liu,Yudan Wang,Kexiao Sang,Chunhong Zhang,Toshifumi Satoh Polym. Chem. 2023 14 1124
2. Asymmetric aldol reaction catalyzed by amino acid tetrapeptides (l-Pro-l-Pro-l-Phe-l-Phe-OMe)
Yaodong Wang,Yudan Wang,Lijia Liu,Kexiao Sang,Chunhong Zhang,Toshifumi Satoh React. Chem. Eng. 2023 8 2022
3. Asymmetric aldol reaction catalyzed by amino acid tetrapeptides (l-Pro-l-Pro-l-Phe-l-Phe-OMe)
Yaodong Wang,Yudan Wang,Lijia Liu,Kexiao Sang,Chunhong Zhang,Toshifumi Satoh React. Chem. Eng. 2023 8 2022
4. 766. Steps towards the synthesis of the histidine-hypertensin analogue. Part I. Synthesis of an intermediate protected heptapeptide
D. Theodoropoulos,J. Gazopoulos J. Chem. Soc. 1960 3861
5. The synthesis and properties of analogues of angiotensin modified in the 1- or the 4-position
M. A. Cresswell,R. W. Hanson,H. D. Law J. Chem. Soc. C 1967 2669
6. Synthesis of analogues of bradykinin with replacement of the arginine residues by 4-guanidinophenyl-L-alanine
Stanley Moore,Harry D. Law,Derek E. Brundish,Donald F. Elliott,Roy Wade J. Chem. Soc. Perkin Trans. 1 1977 2025
7. Antidiabetic in vitro and in vivo evaluation of cyclodipeptides isolated from Pseudomonas fluorescens IB-MR-66e
M. Lozano-González,B. Ovalle-Magallanes,M. Rangel-Grimaldo,S. De la Torre-Zavala,L. G. Noriega,C. Tovar-Palacio,A. R. Tovar,R. Mata New J. Chem. 2019 43 7756
8. Kinetic study on conformational effect in hydrolysis of p-nitroanilides catalyzed by α-chymotrypsin
Yasushi Kawai,Takashi Matsuo,Atsuyoshi Ohno J. Chem. Soc. Perkin Trans. 2 2000 887
9. Conformations of peptides in solution by nuclear magnetic resonance spectroscopy. Part II. Homoallylic coupling in cyclic dipeptides
David B. Davies,Md. Abu Khaled J. Chem. Soc. Perkin Trans. 2 1976 187
10. Amino-acids and peptides. Part XXXVII. Trifluoroacetylation during the coupling of t-butoxycarbonylamino-acids with peptide esters in the presence of trifluoroacetate anion
George A. Fletcher,Miklos L?w,Geoffrey T. Young J. Chem. Soc. Perkin Trans. 1 1973 1162